Laser light therapy has been shown to be effective in improving short-term memory in a study published in Science Advances. Scientists at the University of Birmingham in the UK and Beijing Normal University in China, demonstrated that the therapy, which is non-invasive, could improve short-t
Radiotherapy has become a crucial part of breast cancer treatment, it can also have a severe influence on patients' quality of life, including their emotional, physical, and social wellbeing. It can also cause cancer-related fatigue.
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
According to new research from Boston Medical Center, family involvement in psychosis therapy improves patient results. Studies emphasized that learning to employ motivational interviewing communication skills may assist caregivers in reducing conflict and expressed emotion and improving tre
Even though antiretroviral therapy has made HIV a manageable disease, people living with it often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and qu
"Arvind Kejriwal must tell us how Tihar has been transformed into Thailand where VVIP five stars facilities are given. No therapy recommended watching television, no therapy recommended drinking mineral water, no therapy recommended having a Darbar for 4-5 people. This was being given to Sat
Enzymes, which are crucial to controlling how cells replicate in the human body, could be the very ingredient that encourages DNA to spontaneously mutate - causing potentially permanent genetic errors, according to new research from the University of Surrey.
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement.
Scientists have identified a drug that could be a game-changer for patients. Istradefylline, which is already approved for Parkinson's disease, could reduce not only the harmful effects of cisplatin but also improve its anti-tumour properties.